ceremony opening 

Grignon D. 
Morphological subtyping of renal cell carcinoma

Brunelli M. 
Molecular subtyping of RCC by FISH

Delahunt B. 
Grading and staging of renal cell carcinoma. Advances and controversies

Moch H. 
Molecular basis of renal cancer treatment

Martignoni G. 
Usual and carcinoma-like epithelioid angiomyolipomas: morpho-molecular phenotype, mTOR pathways and therapy

Renner C. 
Studies of CA-IX for imaging and therapy in renal cancer

Müller-Hermelink H.K. 
Pathology the gold standard? The evolution of cancer classifications

Berney D. 
The natural history of prostate cancer

Mikuz G. 
Molecular cytogenetic of prostate cancer, precursor lesions and malignancy associated changes

L.Boccon-Gibod,P.Camparo,E.Comperat 
Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features

Billis A. 
Mimics of adenocarcinoma on needle prostatic biopsy

Srigley J. 
High grade prostatic intraepithelial neoplasia and glandular atypia (ASAP): risk factors for adenocarcinoma

Grignon D. 
Histological variations and variants of prostatic adenocarcinoma

Delahunt B. 
Gleason grading: consensus and controversy

Humphrey P. 
Update on pathological staging of prostate cancer: results of the 2009 International Society of Urological Consensus Meeting

Montironi R. 
Bladder cancer: aetiology

Lopez-Beltran A. 
Bladder cancer: histopathological profile

Hartmann A. 
Tissue microarray studies in bladder cancer

van der Kwast T. 
How to combine the molecular profile with the clinical and pathological profile

Malmström P.U. 
Prevention and screening of bladder cancer

Bussolati G. 
introduzione

Thiene G. 
Cardiovascular pathology: from the anatomical theatre to the double helix

Comperat E. 

Billis A. 

Scarpelli M. 

Nesi G. 

Trias I. 

Algaba F. 

Ayala G. 

Cubilla A.L. 

Berney D. 

Zhou M. 

Algaba F. 
Teratoma

Colecchia M. 
Malignant Teratoma.

Merino M.J. 
Introduction

Nogales F.F. 
Female genital neoplasms with retiform pattern. A network of tumours reproducing an orphan structure

Fletcher C.D.M. 
"New entities" in soft tissue tumours

Merino M.J. 
"New entities" in renal tumours

Rosai J. 
New and difficult entities in surgical pathology: the thyroid

Fletcher C.D.M. 
The changing roles and responsibilities of the modern surgical pathologist

Rosai J. 
Introduction

Young R.H. 
The clear cell

Sobrinho Simões M. 
The oncocytic cell

Rosai J. 
The hyaline cell

Young R.H. 
The hobnail cell

Chan J.K.C. 
The granular cell

Rosai J. 
The rhabdoid cell

Young R.H. 
The spindle cell

Chan J.K.C. 
The cell with nuclear inclusions

Rosai J. 
The signet ring cell

Lugli A. 
CD8+ lymphocytes/tumour budding ratio. A "defender-attacker" approach as a an example of tumour-host interaction

Frattini M. 
Analysis of EGFR gene deregulation and PIK3CA mutations in patients with squamous cell anal cancer (SCAC) treated with concurrent chemoradiation

Lugli A. 
Impact of microsatellite instability, BRAF and specific KRAS mutations G12D and G13D on prognosis in lynch syndromeassociated and sporadic colorectal cancer

Molinari F. 
More sensitive methods to identify K-RAS mutations increase the detection of non-responder in metastatic colorectal cancer (MCRC) patients treated with anti-EGFR monoclonal antibodies (MoAbs)

Frattini M. 
Comprehensive analysis of EGFR and its downstream pathways deregulation identifies the vast majority of metastatic colorectal cancer (MCRC) patients resistant to anti-EGFR monoclonal antibodies (MoAbs)

Portyanko A. 
High grade tumour budding in colorectal cancer is associated with up-regulati on of BIII-tubulin expression at the invasive margin

Zlobec I. 
Diffuse TOPK expression is an adverse prognostic factor in KRAS and BRAF mutated colorectal cancer

Orlowska J. 
Hyperplastic polyposis syndrome in asymptomatic patients: the results from the colorectal-cancer screening program

Marszalek A. 
Inflammation as a co-factor in colorectal neoplasia

Nielsen G.P. 

Hemmings C. 

Collini P. 

Sciot R. 

Mentzel T. 

Sapi Z. 

Forsyth R. 

Hornick J. 

Collin F. 

Coindre J.M. 

Alava E. de 
The clinical relevance of molecular genetics in soft tissue sarcomas

Hogendoorn P. 
Challenging giant cell lesions of bone and soft tissues

Dei Tos A.P. 
Visceral sarcomas: challenges and pitfalls

Antonescu C. 
Pediatric and syndromic GIST: from morphology to genetics

Fletcher C.D.M. 
Recently characterized soft tissue tumours that bring biologic insight

Oliva E. 
Female genital tract

Hornick J. 
Gastrointestinal tract

Sciot R. 
Heart and Blood Vessels

Massi D. 
Skin

Fletcher C.D.M. 
The conceptual evolution of sarcomas classification

Dei Tos A.P. 
The clinical relevance of sarcomas classification

Helman L. 
The use of preclinical data in drafting new strategies for treating round cell sarcomas

Fletcher J. 
Signalling pathways in GIST: beyond KIT and PDGFRA

Casali P. 
Going beyond ifosfamide and anthracyclins: a histotype related therapeutic approach in adults STT

Karagianni F. 
Transgelin in renal fibrosis

Kurrer M. 
Intact B cell follicles identify mixed cellularity (MC) Hodgkin lymphomas (HL) with clinical and prognostic feaures of lymphocyte rich classical HL (CHL)

Tiniakos D. 

Molinari F. 
More sensitive methods to identify K-RAS mutations increase the detection of non-responder in metastatic colorectal cancer (MCRC) patients treated with anti-EGFR monoclonal antibodies (MoAbs)

Lehto V. 
Helsinki Congress 2011

Ponder Sir B. 
Genetic susceptibility to cancer

M.Wells 
closing remarks

Remarks Closing